Remdesivir Use in Pediatric Patients with Acute SARS-CoV-2 Infection Is Safe and Well Tolerated

<b>Background/Objective:</b> Millions of children were infected with SARS-CoV-2, and a small proportion progressed to severe disease, especially those with underlying risk factors. Adult COVID-19 studies showed mortality benefits with Remdesivir. Data on Remdesivir use in pediatrics are limited. We...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Delma J. Nieves, M. Tuan Tran, Jasjit Singh, Negar Ashouri, Tricia Morphew, Jennifer G. Lusk, Felice C. Adler-Shohet, Rachel Marano, Stephanie Osborne, Jennifer Strickland, Antonio C. Arrieta
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2025-03-01
Edice:	Children
Témata:	Remdesivir pediatric COVID-19 SARS-CoV-2 antiviral
On-line přístup:	https://www.mdpi.com/2227-9067/12/3/331
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!